GLOBEALERT
Business● LowSep 29 · Sep 29, 2026, 9:00 AM

AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows

GlobeAlert Desk · curated from South China Morning Post · East Asia

Shares of Akeso surged after British drug maker AstraZeneca moved to advance the Chinese biotech firm’s flagship cancer drug, while a new deal from US giant Merck further underscored the sector’s global momentum amid easing fears of US curbs. AstraZeneca on Tuesday announced a US$2 billion equity investment in Florida-headquartered Summit Therapeutics, which holds the exclusive rights to develop and commercialise Akeso’s immunotherapy drug ivonescimab outside China. Summit and AstraZeneca would...

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.

GlobeAlert context

What the desk knows about this story

Threat level
1 Low

Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.

Sources
1 publisher

Single-source so far. Treat details as unconfirmed until more publishers report.

Category
Business

Not flagged as developing.

East Asia theater · last 7 days
steady · 2 in the last 24h
638
events logged
86
risk index / 100
Wildfires 600Rocket Launches 10Attacks & Assaults 10Prediction Markets 6Kidnappings 4
  • Second jury cant agree on underworld murder chargeAttacks & Assaults · Japan · 4h ago
  • Black clover season 2 episode 7 recap ending explained who killed megicula and what happened to gajaAttacks & Assaults · Japan · 9h ago
  • Mother of japanese abducted by n. korea urges resolution 49 years onKidnappings · North Korea · 20h ago
See the theater on the live map →

More in Business